Literature DB >> 27357268

HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors.

Helena Leijon1, Kaisa Salmenkivi1, Ilkka Heiskanen2, Jaana Hagström1,3, Johanna Louhimo2, Päivi Heikkilä1, Ari Ristimäki1,4, Timo Paavonen5,6, Saara Metso6,7, Hanna Mäenpää8, Caj Haglund2,9, Johanna Arola1.   

Abstract

Pheochromocytomas and paragangliomas are rare, neural crest-originating, neuroendocrine tumors. HuR is an mRNA-binding protein of the ELAV/Hu-protein family, which participates in posttranscriptional regulation of many cancer-associated genes. HuR expression has been connected with aggressive behavior of several malignancies. Cyclooxygenase-2 (COX-2) is also expressed in several malignant tumors, and its expression is regulated by HuR. Tissue microarray of 153 primary pheochromocytomas and paragangliomas was investigated for the expression of HuR and COX-2 proteins by immunohistochemistry using two different HuR antibodies (HuR19F12 and HuR3A). In these tumors, the expression of both intranuclear and cytoplasmic HuR was detectable. Increased cytoplasmic HuR expression was significantly associated with metastatic tumors. Increased COX-2 and MIB-1 expression also was associated with metastatic potential, and moreover, HuR and COX-2 expression correlated with each other. Our data suggest that increased expression of HuR protein is associated with metastatic potential of paragangliomas and pheochromocytomas, and COX-2 seems to be a target of HuR.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HuR; Immunohistochemistry; metastasis; paraganglioma; pheochromocytoma

Mesh:

Substances:

Year:  2016        PMID: 27357268     DOI: 10.1111/apm.12571

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

1.  METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.

Authors:  Ermao Li; Bo Wei; Xiaolan Wang; Ran Kang
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 2.  Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Cytokine Growth Factor Rev       Date:  2016-12-02       Impact factor: 7.638

3.  Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.

Authors:  Xiaohui Xu; Cheng Song; Zhihua Chen; Chenxiao Yu; Yi Wang; Yiting Tang; Judong Luo
Journal:  Cancer Res Treat       Date:  2017-02-24       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.